| Biological Sciences | 2021-2025 | 118 | CN 47 | 99.90 |
| Agricultural, Food and Veterinary Sciences | 2021-2025 | 609 | CN 240 | 97.49 |
| Molecular Medicine | Lifetime | 54 | CN 6 | 98.73 |
| Food Science and Technology | Lifetime | 570 | CN 66 | 98.27 |
| Endocrinology | Lifetime | 157 | CN 4 | 97.54 |
| Pollution | Lifetime | 505 | CN 131 | 96.39 |
| Clinical Neurology | Lifetime | 945 | CN 16 | 93.78 |
| Biotechnology | Lifetime | 470 | CN 30 | 92.55 |
| Microbiology | Lifetime | 630 | CN 20 | 81.16 |
| Aquatic Science and Fisheries | Lifetime | 823 | CN 82 | 66.80 |
| Molecular Medicine | 2021-2025 | 9 | CN 4 | 99.37 |
| Molecular Biology | 2021-2025 | 204 | CN 85 | 99.15 |
| Endocrinology | 2021-2025 | 16 | CN 4 | 96.53 |
| Plant Science | 2021-2025 | 436 | CN 142 | 95.03 |
| Microbiology | 2021-2025 | 63 | CN 6 | 91.27 |
| Biotechnology | 2021-2025 | 93 | CN 25 | 90.01 |
| Epidemiology | 2021-2025 | 927 | CN 94 | 90.46 |
| Ecology | 2021-2025 | 631 | CN 163 | 90.67 |
| Food Science and Technology | 2021-2025 | 460 | CN 143 | 90.36 |
| Pollution | 2021-2025 | 458 | CN 206 | 89.28 |
| Cancer Research | 2021-2025 | 339 | CN 86 | 78.80 |
| Antibiotic Resistance in Bacteria | Lifetime | 100 | CN 4 | 99.59 |
| Vibrio bacteria research studies | Lifetime | 118 | CN 1 | 98.90 |
| Salmonella and Campylobacter epidemiology | Lifetime | 176 | CN 2 | 98.82 |
| Botulinum Toxin and Related Neurological Disorders | Lifetime | 302 | CN 1 | 98.20 |
| Antibiotics Pharmacokinetics and Efficacy | Lifetime | 438 | CN 12 | 97.94 |
| Microplastics and Plastic Pollution | Lifetime | 439 | CN 126 | 97.41 |
| Infections and bacterial resistance | Lifetime | 59 | CN 4 | 97.06 |
| Enzyme Production and Characterization | Lifetime | 725 | CN 47 | 96.61 |
| Bacterial biofilms and quorum sensing | Lifetime | 659 | CN 23 | 96.54 |
| Pharmaceutical and Antibiotic Environmental Impacts | Lifetime | 872 | CN 238 | 96.46 |
| Enterobacteriaceae and Cronobacter Research | Lifetime | 217 | CN 11 | 94.74 |
| Hereditary Neurological Disorders | Lifetime | 322 | CN 5 | 95.03 |
| Inflammatory Biomarkers in Disease Prognosis | Lifetime | 594 | CN 105 | 91.39 |
| Escherichia coli research studies | Lifetime | 744 | CN 13 | 94.97 |
| Sesame and Sesamin Research | Lifetime | 219 | CN 45 | 84.23 |
| Vibrio bacteria research studies | 2021-2025 | 2 | CN 1 | 98.60 |
| Antibiotic Resistance in Bacteria | 2021-2025 | 8 | CN 3 | 99.73 |
| Escherichia coli research studies | 2021-2025 | 16 | CN 3 | 96.16 |
| Bacteriophages and microbial interactions | 2021-2025 | 100 | CN 23 | 96.72 |
| Bacterial biofilms and quorum sensing | 2021-2025 | 62 | CN 9 | 96.76 |
| Antimicrobial Peptides and Activities | 2021-2025 | 82 | CN 37 | 94.91 |
| Antibiotics Pharmacokinetics and Efficacy | 2021-2025 | 129 | CN 10 | 95.55 |
| Bacterial Genetics and Biotechnology | 2021-2025 | 85 | CN 11 | 93.80 |
| Sesame and Sesamin Research | 2021-2025 | 10 | CN 9 | 91.47 |
| Enzyme Production and Characterization | 2021-2025 | 144 | CN 59 | 91.88 |
| Salmonella and Campylobacter epidemiology | 2021-2025 | 190 | CN 32 | 92.23 |
| Bacterial Identification and Susceptibility Testing | 2021-2025 | 263 | CN 21 | 91.71 |
| Infections and bacterial resistance | 2021-2025 | 29 | CN 7 | 88.63 |
| Pneumocystis jirovecii pneumonia detection and treatment | 2021-2025 | 256 | CN 18 | 89.89 |
| Pneumonia and Respiratory Infections | 2021-2025 | 657 | CN 35 | 89.61 |
| Pharmaceutical and Antibiotic Environmental Impacts | 2021-2025 | 920 | CN 506 | 89.14 |
| Antibiotic Use and Resistance | 2021-2025 | 832 | CN 31 | 86.83 |
| Microbial Metabolites in Food Biotechnology | 2021-2025 | 643 | CN 313 | 86.00 |
| Enterobacteriaceae and Cronobacter Research | 2021-2025 | 123 | CN 40 | 77.75 |
| Soybean genetics and cultivation | 2021-2025 | 523 | CN 230 | 79.55 |
| Bone Metabolism and Diseases | 2021-2025 | 862 | CN 389 | 71.09 |